Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Wockhardt’s experimental drug, Zaynich, has shown impressive results, achieving a 100% cure rate in clinical trials for ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of ...

Among 547 episodes of C difficile infection documented in cancer patients in Australia and Spain, 50% were severe and the ...

Environmental toxins like pesticides and heavy metals can lead to blood cancer. Learn how genetics, lifestyle, and exposure ...

A southern Illinois high school is coming together to help a beloved special education teacher and basketball coach battling ...

As a cancer treatment waiting room volunteer, I’ve discovered a unique community of shared experiences and unexpected ...

The Property Group 850 organizes a community bingo event featuring designer handbags to benefit Rally Foundation's childhood ...

LYT-200 now has gained fast track designation from the FDA in acute myeloid leukemia in addition to its prior designation for ...

Preliminary fourth quarter 2024 total revenue of approximately $57.6 million which includes TAVALISSE® net product s ...

Syndax Pharmaceuticals (Nasdaq: SNDX) will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14th at 10:30 a.m. PT/1:30 p.m. ET. Ahead of the presentation, Syndax ...